Cancer: a new killer lymphocyte enters the ring

Published:02.03.21 — A team from EPFL and the Swiss Cancer Centre Léman has discovered that CD4 T lymphocytes, which usually play a supporting role in fighting cancer cells, also have the power to destroy them. 

NotifyMe, a new app to relaunch social events

Published:01.03.21 — NotifyMe is a new app that alerts people who attended an event where there was a risk of COVID-19 infection. The app, using technology developed in part at EPFL, in no way compromises users’ personal data. NotifyMe works well in conjunction with SwissCovid and is currently being pilot-tested at EPFL.

A Kazakh experiment in handwriting

Published:26.02.21 — New EPFL research on whether handwriting skills transfer when a child writes in two different alphabetic scripts may pave the way for cross-lingual digital tools for the detection of handwriting difficulties.

Scientists model a peculiar type of breast cancer

Published:24.02.21 — Scientists led by EPFL have developed a breakthrough in vivo model for invasive lobular carcinoma, a serious yet understudied type of breast cancer. The work will open up previously inaccessible study of the tumor’s biology and help discover new therapies.

Bloom Biorenewables develops biomass-based plastics

Published:23.02.21 — Thanks to technology developed by start-up Bloom Biorenewables, plant materials can be used as an alternative to petroleum derivatives for producing a wide range of products, including bioplastics, textiles, cosmetics and even perfume. The firm recently raised €3.9 million in capital, bringing it one step closer to the manufacturing stage.